DS
CLMT icon

David Shaw’s Calumet Specialty Products CLMT Stock Holding History

David Shaw’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$333K Buy
+9,235
New +$310K ﹤0.01% 4368

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

David Shaw's CLMT Position: Q2 2026 in Review

David Shaw opened a new position in Calumet Specialty Products (CLMT) in Q2 2026: 9,235 shares worth $333K. The stake represents ﹤0.01% of the portfolio and ranks #4368 among its holdings.

187 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • David Shaw held 9,235 shares of Calumet Specialty Products worth $333K as of Q2 2026.
  • Calumet Specialty Products was a new David Shaw position in Q2 2026.
  • Calumet Specialty Products made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #4368 holding.
  • 187 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.